PlushCare GLP-1 at a glance: An established Accolade-owned telehealth platform with a $99/month membership model offering FDA-approved branded GLP-1 (Wegovy + Zepbound) prescribed by board-certified U.S. primary care physicians via same-day video appointments, insurance acceptance from major U.S. health plans for eligible patients, and prior-authorization handling for branded GLP-1. HSA/FSA accepted. All 50 states subject to state-specific licensure. Best for buyers whose insurance plan covers FDA-approved GLP-1 — or who want a brand-name medication path with physician-led care and PA support. Skip if your insurance doesn't cover GLP-1 and you'd rather pay a flat compounded cash-pay price elsewhere, or if you prefer async-only intake without video visits.
✓ Pick PlushCare if
You want an FDA-approved branded GLP-1 path (Wegovy, Zepbound); you have insurance that may cover GLP-1 or are willing to pursue prior authorization; you value board-certified primary care physicians with same-day video visits over async-only intake; you want prior-authorization handling; you want an established Accolade-owned platform; you want HSA/FSA eligibility.
✕ Skip PlushCare if
You don't have GLP-1-covered insurance and want the cheapest cash-pay compounded path; you don't want to pay a $99 monthly membership on top of medication; you prefer async-only intake without video visits; you have GLP-1 contraindications.
Our verdict on PlushCare GLP-1
- Best for
- Buyers whose insurance plan may cover FDA-approved GLP-1 (Wegovy, Zepbound), or who want a brand-name path with same-day video visits and PA support from an established Accolade-owned platform.
- GLP-1 strengths
- Established Accolade-owned telehealth platform with meaningful brand history; FDA-approved branded GLP-1 path (Wegovy + Zepbound) prescribed by board-certified U.S. primary care physicians; insurance acceptance from major U.S. health plans for eligible patients; same-day video appointments; prior-authorization handling for branded GLP-1; $99/month membership model; HSA/FSA eligibility; all 50 states subject to state-specific licensure; comprehensive Privacy Policy + Terms + Telehealth Consent + HIPAA Notice published.
- GLP-1 drawbacks
- $99 membership fee in addition to medication costs and any plan copays; insurance coverage for GLP-1 is plan-dependent and may require step therapy or BMI thresholds; medication cost without insurance coverage can be high (Wegovy ~$1,300-$1,500, Zepbound ~$1,000-$1,300 retail before manufacturer savings); not the cheapest cash-pay path for buyers without GLP-1-covered insurance.
- GLP-1 pricing
- $99/month membership. Medication cost is plan-dependent (plan copay with covered insurance) or retail / manufacturer savings (Wegovy / Zepbound) if uninsured for GLP-1. HSA/FSA accepted.
- Editor's rating
- 4.4 / 5 — Established Accolade-owned platform + FDA-approved branded GLP-1 + insurance acceptance + same-day video visits.
Start with PlushCare today
Established Accolade-owned telehealth. Wegovy + Zepbound path. Insurance acceptance. Same-day video. $99/mo membership. HSA/FSA.
Visit PlushCare's Official Site →The PlushCare GLP-1 menu
External evidence reference: STEP-1 NEJM 2021 for semaglutide and SURMOUNT-1 NEJM 2022 for tirzepatide. FDA semaglutide guidance.
What we verified about PlushCare GLP-1
| What we checked | What we found |
|---|---|
| Brand & entity VERIFIED | PlushCare · part of the Accolade family |
| Domain & weight-loss URL VERIFIED | plushcare.com/weight-loss |
| Established Accolade-owned telehealth platform VERIFIED | Parent-company trust signal |
| FDA-approved branded GLP-1 (Wegovy, Zepbound) VERIFIED | Prescribed by board-certified physicians |
| Insurance acceptance from major U.S. plans VERIFIED | Plan-dependent for GLP-1 medication itself |
| Prior-authorization handling for branded GLP-1 VERIFIED | Care team support |
| $99/month membership model VERIFIED | Confirm current pricing at signup |
| Board-certified primary care physician network VERIFIED | U.S. licensed MDs |
| Same-day or next-day video appointments VERIFIED | Live video visits, not async-only intake |
| HSA/FSA eligible VERIFIED | Accepted for membership and visit fees; LMN available on request |
| All 50 states VERIFIED | Subject to state-specific licensure |
| Privacy Policy + Terms + Telehealth Consent + HIPAA Notice VERIFIED | Reviewed before purchase |
| Wegovy + Zepbound manufacturer savings programs VERIFIED | Available for eligible commercially-insured patients via Novo Nordisk / Eli Lilly |
| Step-therapy or BMI thresholds (insurer-dependent) CAUTION | Plan-dependent; confirm with your insurer before signup |
| Medication retail cost without coverage CAUTION | Wegovy ~$1,300-$1,500/mo, Zepbound ~$1,000-$1,300/mo before manufacturer savings |
| Compounded GLP-1 path CAUTION | Editorial positioning emphasizes FDA-approved branded; confirm current compounded options at signup |
All claims verified on plushcare.com/weight-loss as of June 2026. PlushCare's established Accolade-owned positioning, FDA-approved branded GLP-1 path, and insurance acceptance are meaningful differentiators from compounded-only newer-entrant competitors.
FDA-approved branded vs. compounded — the PlushCare path
PlushCare's editorial positioning emphasizes FDA-approved branded GLP-1 — Wegovy (semaglutide) and Zepbound (tirzepatide) — prescribed by board-certified U.S. physicians and routed through pharmacy with insurance billing where applicable. This is meaningfully different from cash-pay-only compounded-GLP-1 platforms because:
- Branded medication is FDA-approved for chronic weight management with established clinical-trial evidence (STEP-1 for Wegovy, SURMOUNT-1 for Zepbound), versus compounded products which carry the standard FDA disclosure that they are not FDA-approved or evaluated for safety, efficacy, or quality.
- Insurance acceptance means eligible patients may pay only a plan copay rather than full retail.
- Prior-authorization handling is bundled into the care team's workflow.
The 2026 GLP-1 regulatory landscape
The FDA resolved the official semaglutide GLP-1 shortage in early 2025. Per FDA compounding guidance, mass compounding is restricted outside narrow patient-specific exceptions. Platforms with FDA-approved branded paths have a more durable post-shortage position than compounded-only competitors.
PlushCare GLP-1 pros and cons
✓What we like
- Established Accolade-owned telehealth platform with meaningful brand history
- FDA-approved branded GLP-1 path (Wegovy + Zepbound) — clinical trial-backed
- Insurance acceptance from major U.S. health plans for eligible patients
- Prior-authorization handling for branded GLP-1
- Board-certified primary care physicians with U.S. licensure
- Same-day or next-day video appointments — not async-only intake
- $99/month membership bundles unlimited primary care visits beyond GLP-1
- HSA/FSA accepted with LMN on request
- All 50 states subject to state-specific licensure
- Comprehensive Privacy Policy + Terms + Telehealth Consent + HIPAA Notice published
✕Where PlushCare GLP-1 falls short
- $99 membership fee in addition to medication costs and any plan copays
- Insurance coverage for GLP-1 is plan-dependent — may require step therapy or BMI thresholds
- Retail medication cost without coverage is high (Wegovy ~$1,300-$1,500, Zepbound ~$1,000-$1,300)
- Not the cheapest cash-pay path for buyers without GLP-1-covered insurance
- Editorial positioning emphasizes branded over compounded — fewer compounded options if you want a flat low cash-pay price
- Prior-authorization timing can vary by insurer (days to weeks)
Start with PlushCare today
Established Accolade-owned. Branded Wegovy + Zepbound. Insurance accepted. Same-day video visits.
Visit PlushCare's Official Site →PlushCare GLP-1 sign-up & ongoing-care checklists
Before sign-up
- Check your insurance for GLP-1 (Wegovy / Zepbound) coverage and step-therapy or BMI thresholds.
- Check Wegovy + Zepbound manufacturer savings eligibility if commercially insured.
- Confirm $99/month membership + visit fee structure.
- Confirm state availability.
- Read Terms + Telehealth Consent + HIPAA Notice.
- Book same-day video visit.
After sign-up
- Complete board-certified physician video visit.
- Receive Wegovy / Zepbound prescription + PA submission.
- Pick up prescription at pharmacy after PA approval.
- Set up injection supplies.
- Start titration per physician.
- Use member portal for follow-up visits.
Canceling PlushCare
- Use account dashboard.
- Or contact Member Support.
- Cancel a few days before billing.
- Request written confirmation.
- Discuss safe off-ramp with physician if mid-titration.
- Save prescription transfer records.
PlushCare GLP-1 frequently asked questions
How much does PlushCare GLP-1 program cost in 2026?
$99/month membership. Medication cost is plan-dependent (plan copay with covered insurance) or retail / manufacturer savings (Wegovy / Zepbound) if uninsured for GLP-1. HSA/FSA accepted. Confirm current pricing at signup.
Is PlushCare GLP-1 program legit?
Yes — PlushCare is an established telehealth platform owned by Accolade, with board-certified U.S. primary care physicians, same-day video appointments, and prior-authorization handling for FDA-approved branded GLP-1. The parent-company relationship is a meaningful trust signal vs. newer entrants.
What GLP-1 medications does PlushCare offer?
FDA-approved branded GLP-1s including Wegovy (semaglutide) and Zepbound (tirzepatide) for eligible patients meeting BMI and clinical criteria. Coverage depends on your insurance plan.
Does PlushCare accept insurance for GLP-1?
Yes — PlushCare accepts most major U.S. health insurance plans for the visit, and assists with prior authorization for FDA-approved branded GLP-1. Whether your plan covers the GLP-1 medication itself is plan-dependent.
How quickly does PlushCare provide GLP-1 access?
Same-day or next-day video appointments are typically available. Prior-authorization for branded GLP-1 can take days to weeks depending on the insurer.
Is PlushCare HSA/FSA eligible?
Yes — accepted for membership and visit fees. Letter of Medical Necessity available on request.
Is PlushCare available in all 50 U.S. states?
Subject to state-specific telehealth licensure. Confirm at signup.
How do I cancel PlushCare?
Account dashboard or Member Support. Cancel a few days before next billing. If mid-titration on GLP-1, discuss safe off-ramp with the physician.
Does PlushCare offer compounded GLP-1?
PlushCare's editorial positioning emphasizes FDA-approved branded GLP-1 via insurance + manufacturer savings rather than compounded sema/tirz — confirm current medication path at signup.
What should I verify before signing up with PlushCare?
Whether your insurance plan covers FDA-approved branded GLP-1, BMI / step-therapy thresholds your insurer requires, your specific plan copay after PA, Wegovy / Zepbound manufacturer savings eligibility, and state availability.
Honest verdict — should you choose PlushCare?
PlushCare earns its 4.4/5 GLP-1 editor's rating on five distinctive features. First: established Accolade-owned telehealth platform — meaningful brand history and parent-company trust signal that newer entrants don't yet have. Second: FDA-approved branded GLP-1 path (Wegovy + Zepbound) — rare and clinically meaningful vs. compounded-only competitors. Third: insurance acceptance from major U.S. health plans plus prior-authorization handling. Fourth: board-certified primary care physicians with same-day video appointments rather than async-only intake. Fifth: $99/month membership model with HSA/FSA eligibility.
The bottom line
If you want a brand-name GLP-1 path (Wegovy or Zepbound) with insurance support from an established Accolade-owned platform, PlushCare is editorially appealing. However: if your insurance doesn't cover GLP-1 and you'd rather pay a flat compounded cash-pay price elsewhere, the $99 membership + retail medication cost can be expensive. Confirm your plan's GLP-1 coverage and step-therapy / BMI thresholds before signup, and check Wegovy / Zepbound manufacturer savings eligibility if commercially insured.
Start with PlushCare today
Established. Branded Wegovy + Zepbound. Insurance accepted. Same-day video.
Visit PlushCare's Official Site →Published: June 15, 2026 · Verified: June 2026 · Spot a factual issue? Tell our editors.